Fragment C (TetC) is a non-toxic 47 kDa polypeptide fragment of tetanus toxin that can be used as a subunit vaccine against tetanus. Expression of TetC in Escherichia coli and yeast was dependent on the availability of synthetic genes that were required to improve translation ef®ciency and stabilize the mRNA. To explore the feasibility of producing TetC in tobacco leaves, we attempted expression of both the bacterial high-AT (72.3% AT) and the synthetic higher-GC genes (52.5% AT) in tobacco chloroplasts. We report here that the bacterial high-AT mRNA is stable in tobacco chloroplasts. Signi®cant TetC accumulation was obtained from both genes, 25 and 10% of total soluble cellular protein, respectively, proving the versatility of plastids for expression of unmodi®ed high-AT and high-GC genes. Mucosal immunization of mice with the plastidproduced TetC induced protective levels of TetC antibodies. Thus, expression of TetC in chloroplasts provides a potential route towards the development of a safe, plant-based tetanus vaccine for nasal and oral applications.
INTRODUCTION
There is much interest in plant-based vaccines, which may be produced from genes stably incorporated in the nuclear genome, from plant viral vectors or by transient Agrobacterium-mediated gene delivery (1±4). Initial developments in the ®eld of plant-based vaccines have been limited by low-level expression of immunogen from nuclear genes. An alternative method is to express vaccine antigens from the plastid genome, offering signi®cant advantages over nuclear gene expression (5±7).
Our objective was to explore the feasibility of producing a mucosal tetanus vaccine by expressing the Fragment C domain of the tetanus toxin (TetC) in tobacco chloroplasts.
TetC is a non-toxic 47 kDa polypeptide fragment shown to induce a protective immune response following parenteral immunization with preparations from Escherichia coli (8) , yeast (9) and insect cells (10) . Expression of TetC in E.coli was shown to be limited by the unfavorable codon bias of the highly AT-rich Clostridium tetani coding sequence; expression levels could be increased from a synthetic gene to~14% of cell protein (11) . Since proteins expressed in E.coli may contain toxic cell wall pyrogens, TetC expression was also attempted in the non-toxic host Saccharomyces cerevisiae (9) . The AT-rich C.tetani DNA could not be expressed in yeast due to the presence of several fortuitous polyadenylation sites which gave rise to truncated mRNAs. TetC accumulation was obtained when a codon-optimized high-GC gene, lacking the polyadenylation sites, was expressed in yeast. However, the yeast-produced TetC secreted in the culture medium was inactive as an immunogen due to glycosylation.
We report here that, in tobacco plastids, mRNAs expressed from both the high-AT bacterial and high-GC synthetic genes are stable. Signi®cant TetC accumulation was obtained from both genes, 25 and 10% of TSP, respectively, proving the versatility of plastids for the expression of both high-AT and high-GC genes. Immunization of mice with the plastidproduced TetC induced protective levels of TetC antibodies, con®rming the potential of chloroplasts for the production of a plant-based mucosal vaccine.
MATERIALS AND METHODS

Construction of transformation vectors
The TetC polypetide was expressed in chloroplasts from two different coding regions: the native AT-rich bacterial gene (tetC-AT) and a synthetic, relatively GC-rich sequence (tetC-GC). The tetC coding regions were PCR ampli®ed to introduce an NdeI site including the translation initiation codon (ATG) and an XbaI site downstream of the stop codon. The tetC-AT coding region was PCR ampli®ed with primers 5¢-CGGGTACCCATATGAAAAATCTGGATTGTTGGGT-CGACAATGAAG-3¢and 5¢-CGTCTAGAAATTAATCATT-TGTCCATC-3¢. The tetC-GC coding region was PCR *To whom correspondence should be addressed. Tel: +1 732 445 5329; Fax: +1 732 445 5735; Email: maliga@waksman.rutgers.edu ampli®ed with primers 5¢-CGGGTACCCATATGAAAAA-CCTTGATTGTTGG-3¢ and 5¢-GCTCTAGATTAGTCGT-TGGTCCAACCT-3¢. Templates for PCR ampli®cation were plasmid pcDNA3/ntetC (tetC-AT ) (12) and pcDNA3/tetC (tetC-GC ) (13) .
Plasmids pJST10 and pJST11 were obtained by replacing the neo coding region in plasmid pHK40 with the tetC-AT and tetC-GC coding regions as NdeI±XbaI fragments, respectively. Plasmid pHK40 is a plastid transformation vector derived from plasmid pPRV111A (14) , with a spectinomycin resistance (aadA) gene as a selective marker and a neo gene expressed in a cassette consisting of a PrrnLT7g10 cassette and the rbcL 3¢-UTR (TrbcL). The tetC genes are divergently oriented relative to the rrn operon (Fig. 1B) .
Plasmid pJST12 was obtained by replacing the neo coding region in plasmid pHK73 with the tetC-AT coding region as an NdeI±XbaI fragment. Plastid transformation vector pHK73 is a pPRV111B vector derivative in which the neo coding region is expressed in a cassette consisting of a PrrnLatpB cassette (plastid rrn operon promoter fused with atpB leader and an NdeI site including the ATG) and TrbcL. The PrrnLatpB cassette is identical to the cassette in plasmid pHK11 (15) , except that an NdeI site was created by replacing AT with a CA at the ±3/±2 position upstream of the ATG. The tetC gene in plasmid pJST12 is in tandem orientation with the rrn operon (Fig. 1B) .
Plastid transformation
Plastid transformation was carried out as described previously (16) . DNA for plastid transformation was prepared using the QIAGEN Plasmid Maxi Kit (Qiagen Inc., Valencia, CA). Transforming DNA was introduced into leaf chloroplasts on the surface of tungsten particles (1 mm) using the Du Pont PDS1000He Biolistic gun. Transplastomic plants were selected on RMOP medium containing 500 mg/l spectinomycin dihydrochloride. The transgenic plants were grown on Murashige-Skoog (MS) medium (17) containing 3% (w/v) sucrose and 0.6% (w/v) agar in sterile culture condition. A uniform population of transformed plastid genome copies was con®rmed by DNA gel blot analysis. Double-stranded DNA probes were prepared by random-primed 32 P-labeling using the Ready-To-Go DNA Labeling Beads (Amersham Pharmacia Biotech, Piscataway, NJ). The probes were: rrn16-rps12 plastid targeting region, ApaI±EcoRV ptDNA fragment; aadA, NcoI±XbaI coding region; tetC-AT and tetC-GC coding region, NdeI±XbaI fragments.
RNA gel blot analysis
RNA gel blot analysis was carried out as described previously by loading 3 mg total cellular RNA per lane (18) . The templates for probing the tetC genes were NdeI±XbaI coding region fragments. The template for probing the tobacco cytoplasmic 25S rRNA was a PCR fragment ampli®ed from total tobacco cellular DNA with primers 5¢-TCACCT-GCCGAATCAACTAGC-3¢ and 5¢-GACTTCCCTTGCCT-ACATTG-3¢. Probes were prepared by random-primed 32 P-labeling (see above). RNA hybridization signals were quanti®ed using a Molecular Dynamics PhosphorImager and normalized to the 25S rRNA signal.
SDS±PAGE and immunoblotting
Leaves for protein extraction were taken from greenhouse plants. To obtain total soluble leaf protein,~200 mg of leaf was homogenized in 1 ml of buffer containing 50 mM HEPES±KOH (pH 7.5), 10 mM potassium acetate, 5 mM magnesium acetate, 1 mM EDTA, 1 mM or 10 mM DTT and 2 mM PMSF (10 mM DTT is 10 times more than we normally include in the extraction buffer). Insoluble material was removed by centrifugation. Protein concentrations were determined by the Bradford Protein Assay Reagent kit (BioRad, Hercules, CA). Immunoblot analysis of TetC accumulation was carried out as described previously (19) . In some experiments, in addition to mercaptoethanol (2.5%), 10 mM DTT was also included. The anti-TetC antibody was provided by Dr C. Turcotte, Imperial College, London. TetC was quanti®ed on the immunoblots by densitometric analysis with the DensoSpot program of Alpha Imager 2000 (Alpha Innotech, San Leandro, CA) by comparison of the experimental samples with a recombinant TetC (rTetC) dilution series. Puri®ed His 6 -tagged rTetC, expressed in a Novagen pET28a vector, was kindly provided by Mr O. Qazi, Imperial College, London.
Nasal immunization of mice
All mice were obtained from B & K suppliers (Scunthorpe, UK). For nasal immunization, a 15 ml volume of concentrated protein solution from plants expressing TetC or appropriate controls was applied to BALB-C female mice, 7.5 ml per nare. Protein extracts were prepared as for SDS±PAGE and concentrated using a Centriprep YM-10 (Millipore Ltd, Watford, UK). Cholera toxin (CT; 1 mg per dose) was added to nasal vaccines to act as mucosal adjuvant. Control TetC (rTetC) for mucosal immunization was prepared from E.coli. Mice were tail-bled at day 27 and samples stored at ±20°C until assayed. On day 45 the mice were sacri®ced by exsanguinations of the heart to collect serum samples. Lung and gut washes were performed, with 1 ml PBS containing protease inhibitors, Roche Complete protease inhibitor cocktail (Roche Diagnostics Ltd, Mannheim, Germany). All samples were stored at ±20°C until required. For tetanus toxin challenge, mice were injected sub-cutaneously in the right¯ank with 0.5 ml PBS containing 50 PD 50 of tetanus toxin (kindly provided by Dr Thea Sesardic, NIBSC) and sacri®ced as soon as they showed symptoms of paralysis.
ELISAs for anti-TetC antibodies
Samples were assayed for anti-TetC IgG in serum and antiTetC IgA in mucosal surface washes as described previously (20) . For IgG measurements, samples were serially diluted in PBS containing 0.05% Tween-20 (PBST); for IgA readings, samples were serially diluted in PBST containing protease inhibitors (Roche Complete protease inhibitor cocktail). Microtiter plates were coated with 3 mg/ml TetC. Serum anti-TetC was determined with goat anti-mouse IgG (g-chain speci®c) antisera conjugated with alkaline phophatase (SigmaAldrich, Dorset, UK). Mucosal anti-TetC IgA was determined with goat antiserum against mouse IgA (a-chain speci®c) conjugated to streptavidin (Sigma-Aldrich); this was then detected with biotinylated alkaline phosphatase (Dako, Ely, UK). Response was measured against the color change of OPD 
RESULTS
Construction of transplastomic tobacco plants with tetC genes
The TetC polypeptide was expressed in tobacco chloroplasts from three different genes (Fig. 1A) . Plastid vectors pJST10 and pJST12 encode the AT-rich tetC (tetC-AT; 72.3% AT) native coding region derived from C.tetani. Vector pJST11 encodes a more GC-rich synthetic tetC reading frame, successfully expressed in yeast (tetC-GC; 52.6% AT) (9). The tetC coding regions in plastids were expressed from the strong plastid rRNA operon (Prrn) promoter fused with a DNA segment encoding the T7 phage gene 10 (pJST10, pJST11) or the plastid atpB (pJST12) 5¢-UTR. The engineered tetC genes were cloned in suitable plastid vectors (Fig. 1B) and introduced into the tobacco plastid genome by standard protocols. Incorporation of the tetC genes in the plastid genome was con®rmed by DNA gel blot analysis (Fig. 1C) . Several independently transformed lines were obtained with each of the constructs. The phenotype of plants transformed with vector pJST11 and pJST12 (Nt-pJST11, Nt-pJST12) was similar to the wild-type, non-transformed plants. The NtpJST10 plants grew slower in the greenhouse and had a chlorotic (pigment de®cient) phenotype (Fig. 2) . Since plants derived from independent transformation events were similar, data are shown only for one transformed clone per construct.
Expression of the tetC genes in chloroplasts
RNA gel blot analysis con®rmed transcript accumulation for each of the three tetC genes (Fig. 3A) . The Nt-pJST10 and NtpJST11 plants contained monocistronic messages, whereas the Nt-pJST12 plants accumulated both monocistronic and dicistronic transcripts due to read-through transcription through TrbcL (Fig. 1B) . Steady-state tetC transcript levels in the Nt-pJST10 and Nt-pJST12 leaves were comparable (Fig. 3A) . Relative amounts of tetC-GC transcripts in the NtpJST11 plants could not be determined, as the coding region probes did not cross-hybridize.
The ®delity of TetC protein expression in chloroplasts was con®rmed by immunoblot analysis of protein extracts separated by SDS±PAGE (Fig. 3B and C) . Two polypeptides were recognized by anti-TetC antisera: a 47-kDa protein that comigrated with the Rubisco large subunit (LSU) and a 43-kDa protein, also visible in Coomassie Blue-stained SDS±PAGE gels (Fig. 3B) . The 43-kDa band is the full-size TetC protein as it has both the intact TetC N-and C-termini based on microsequencing gel-puri®ed protein (Edman degradation and ESI-MS/MS; data not shown) and has higher mobility than the His 6 -tagged rTetC control. The N-terminal amino acid sequence of the 43-kDa protein was MKNLD, indicating that the initiator methionine is not removed post-translationally. Thus, the 47 kDa protein is apparently a modi®ed TetC. Other prominent bands on the gels are the Rubisco large and small subunits (LSU and SSU, respectively, in Fig. 3B ) that together constitute~50% of TSP in wild-type plants. Examination of western blots using densitometry and puri®ed TetC standards showed TetC protein to be~25% TSP in the leaves of Nt-pJST10 plants and~10% TSP in NtpJST11 and Nt-pJST12 leaves (Fig. 3C) . TetC levels in different experiments were in the 18±27% range in Nt-pJST10 leaves and in the 7±10% range in Nt-pJST11 and Nt-pJST12 leaves. The Nt-pJST10 plants, but not the Nt-pJST11 or NtpJST12 plants, have a mutant phenotype (Fig. 2) . Since the NtpJST10 leaves contain the highest TetC level,~25% TSP, the mutant phenotype may be directly linked to TetC expression levels.
Immunization of mice with leaf protein extract harboring TetC
Groups of mice were immunized intranasally with vaccines harboring extracts from transgenic tobacco leaves mixed with small amounts of puri®ed CT acting as adjuvant (Fig. 4A) . The mice were primed on day 0. First blood samples were taken on day 27. The mice were boosted at days 28 and 35. Final mucosal surface wash samples and sera were collected on day 45. Control mice were immunized with recombinant TetC puri®ed from E.coli (rTetC) and mixed with CT, nontransgenic leaf extract (wild-type) or PBS (naive mice sample).
All groups of mice immunized with extract from transgenic plants expressing TetC had a signi®cant systemic anti-TetC IgG response at day 27 (Fig. 4B) . Levels of speci®c anti-TetC IgG were boosted after re-immunization at days 28 and 35. Anti-TetC IgA antibody responses were seen at the immunized site in nasal washes (Fig. 4C) and at a distal site in gut washes (Fig. 4D ). Mice immunized with non-transgenic leaf extract or buffer alone (PBS) failed to mount a detectable TetC-speci®c antibody response. Levels of anti-TetC antibodies, comparable to those obtained here, have consistently been observed to confer solid protection against a toxin challenge (21).
In order to test if the anti-TetC antibody responses raised in the intranasal trial were protective, ®ve mice of the JST10-CT group were challenged with tetanus toxin (50 PD 50 ; 50Q the dose required to cause paralysis in 50% of mice). IgG titers of the mice were: 364183, 489583, 413829, 218493 and 375292 (note that the values overlap on the plot). As a control group, ®ve naive mice were used. The mice were monitored at 6 h time points (four times a day) after inoculation for 5 days. The ®rst two positive mice in the naive group were seen at 24 h. The rest of the naive mice developed symptoms of paralysis by 42 h. All mice immunized with leaf extract harboring the plant-derived TetC survived the challenge and were free of symptoms.
DISCUSSION
We report here high-level TetC accumulation from both native bacterial high-AT (~25% of TSP) and the synthetic high-GC (~10% of TSP) tetC genes, con®rming the utility of plastids for the expression of unmodi®ed genes from diverse sources.
Expression of TetC from the native bacterial coding sequence was feasible, because the mRNA transcribed from the tetC-AT gene was stable. Although plants are eukaryotes, their plastids share some features of prokaryotic machinery for mRNA turnover (22, 23) , explaining why tetC mRNA is not degraded in plastids. Another example for a bacterial gene that is unstable in a eukaryotic (plant nucleus) environment but stable in plastids is the Bacillus thuringiensis (Bt) Cry1Ac insecticidal protein gene (24, 25) . Interestingly, mRNAs derived from the tetC-GC gene (this study) and the high-GC bacterial bar (68.3%) (26) were also stable, indicating the compatibility of plastid degradation machinery with mRNAs from diverse sources.
Studies in heterologous expression hosts have shown that codon usage can greatly in¯uence the level of expression of foreign proteins (27, 28) . The importance of codon bias in plastids was investigated here by expressing the native bacterial AT-rich (72.3% AT) and codon-modi®ed more GC-rich (52.6% AT) tetC genes. The AT-rich gene reproducibly yielded about twice as much TetC as the GC-rich gene in the same cassette:~25% of TSP compared with~10% of TSP. More ef®cient translation of the bacterial tetC-AT coding region re¯ects the plastid genome's codon bias, which is also relatively AT-rich (29) . A similar (1.5-fold) increase in protein level was observed when comparing expression from bacterial and codon optimized synthetic CP4 genes (30) . Thus, the increase in protein levels that may be obtained by codon optimization is relatively modest, and it is in a few-fold range. A relatively small effect of codon modi®cation on protein yields was predictable, as in tobacco plastids there is no example for low codon usage frequencies (1.4/2.1 per 1000 codons) that are correlated with problems of expressing eukaryotic cDNAs in E.coli (27, 28) . Based on 19 tobacco plastid gene sequences (4245 codons; NCBI Codon Usage Database), the least frequently used codons are UGC and CGC (3.5 per 1000 codons) followed by CCG, CGG and AGG (4.0, 4.2 and 4.9 per 1000 codons, respectively). The relatively modest (few-fold) gains obtainable by codon modi®cation in Nicotiana tabacum, a higher plant, contrast with the 80-fold increase obtained by codon optimization in the chloroplasts of Chlamydomonas reinhardtii, a unicellular alga (31) . In higherplant plastids, the targets for engineering protein expression are the translation control signals, which may affect protein accumulation in the 10 000-fold range (reviewed in 6,7) (14, 15, 30) .
The Nt-pJST10 plants are the ®rst transplastomic plants in which high-level protein accumulation (~25% of TSP) expressed from a transgene causes a mutant phenotype. A mutant phenotype in a different transplastomic line, with a low level of heterologous protein expression (0.26% of TSP), is caused by competition for a gene-speci®c mRNA maturation factor (32) . We assume that abnormal chloroplast development in the Nt-pJST10 plants is due to high-level TetC accumulation, as expression of a different protein, neomycin phosphotransferase II, at~23.00 T 5.4% TSP from the same cassette did not result in chlorophyll de®ciency (14) .
Anti TetC-antisera detected two TetC forms. We believe the 43 kDa form to be the intact TetC, based on intact N-and C-termini, and mobility that is faster than that of the Histagged control rTetC. The reason for the altered mobility of the slower (47 kDa) TetC form is unknown. Increasing the concentration of DTT in the isolation buffer and in SDS±PAGE did not prevent formation of the two bands (data not shown), a treatment that prevented formation of an artefact in E.coli-produced TetC (8). Glycosylation was also considered as the reason for the mobility shift since TetC has seven potential sites for Asn-linked glycosylation. Modi®cation of these sites in yeast shifted TetC mobility to 65 kDa or higher (9) . We consider glycosylation of TetC in plastids unlikely as the observed shift was minor and the enzymatic machinery for glycosylation is localized to the endoplasmic reticulum and Golgi apparatus (33) .
We report here that TetC produced in tobacco leaf is effective for mucosal immunization of mice when applied nasally and orally (data not shown), and protects mice from a tetanus toxin challenge. Thus, TetC is a new addition to the list of vaccines that may be produced in plants.
